4.8 Article

Polygenic prediction via Bayesian regression and continuous shrinkage priors

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-09718-5

关键词

-

资金

  1. National Institutes of Health (NIH) [U01HG008685, K99AG054573]
  2. Government of Canada through Genome Canada
  3. Canadian Institutes of Health Research
  4. 'Ministere de l'Economie, de la Science et de l'Innovation du Quebec' through Genome Quebec
  5. National Institutes of Health [U19CA148065, X01HG007492]
  6. Cancer Research UK [C1287/A10118, C1287/A16563, C1287/A10710]
  7. European Union [HEALTH-F2-2009-223175, H2020 633784, 634935]
  8. [PSR-SIIRI-701]

向作者/读者索取更多资源

Polygenic risk scores (PRS) have shown promise in predicting human complex traits and diseases. Here, we present PRS-CS, a polygenic prediction method that infers posterior effect sizes of single nucleotide polymorphisms (SNPs) using genome-wide association summary statistics and an external linkage disequilibrium (LD) reference panel. PRS-CS utilizes a high-dimensional Bayesian regression framework, and is distinct from previous work by placing a continuous shrinkage (CS) prior on SNP effect sizes, which is robust to varying genetic architectures, provides substantial computational advantages, and enables multivariate modeling of local LD patterns. Simulation studies using data from the UK Biobank show that PRS-CS outperforms existing methods across a wide range of genetic architectures, especially when the training sample size is large. We apply PRS-CS to predict six common complex diseases and six quantitative traits in the Partners HealthCare Biobank, and further demonstrate the improvement of PRS-CS in prediction accuracy over alternative methods.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据